MEFV gene 3′-UTR Alu repeat polymorphisms in patients with familial Mediterranean fever

Clinical and Experimental Rheumatology

Volumn 26, Issue 4 SUPPL. 50, 2008, Pages

  Üstek, Duran ^a   Ekmekçi, Cumhur ^a   Oku, Başar ^a   Coşan, Fulya ^a   Çakiris, Aris ^a   Abaci, Neslihan ^a   Çelik, Selda ^b   Kamali, Sevil ^a   Hatemi, Gülen ^b   Kasapçopur, Özgür ^b   Özdoǧan, Huri ^b   Gül, Ahmet ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

3 untranslated region; Alu repeats; Familial Mediterranean fever; Gene expression; MEFV

Indexed keywords

PROTEIN; PYRIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; ALU SEQUENCE; ARTICLE; AUTOINFLAMMATORY DISEASE; AUTOSOMAL RECESSIVE DISORDER; CONTROLLED STUDY; DNA POLYMORPHISM; DNA SEQUENCE; ETHNICITY; EXON; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE STRAND CONFORMATION POLYMORPHISM; TURKEY (REPUBLIC);

3' UNTRANSLATED REGIONS; ALU ELEMENTS; CASE-CONTROL STUDIES; CYTOSKELETAL PROTEINS; FAMILIAL MEDITERRANEAN FEVER; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 55049111530     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. ONEN F: Familial Mediterranean fever. Rheumatol Int 2006; 26: 489-96.
2. STOJANOV S, KASTNER DL: FamiliGl autoinflammatory diseases: genetics, pathogenesis and treatment. Curr Opin Rheumatol 2005; 17: 586-99.
3. MASTERS SL, LOBITO AA, CHAE J, KASTNER DL: Recent advances in the molecular pathogenesis of hereditary recurrent fevers. Curr Opin Allergy Clin Immunol 2006; 6: 428-33.
4. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium. Cell 1997; 90: 797-807.
5. A candidate gene for familial Mediterranean fever. The French FMF Consortium. Nat Genet 1997; 17: 25-31.
6. TING JP, KASTNER DL, HOFFMAN HM: CATERPILLERs, pyrin and hereditary immunological disorders. Nat Rev Immunol 2006; 6: 183-95.
7. TOUIAOU I, LESAGE S, MCDERMOTT M et al.: Infevers: an evolving mutation database for auto-inflammatory syndromes. Hum Mutat 2004; 24: 194-8.
8. CHAE JJ, WOOD G, MASTERS SL et al.: The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production. Proc Natl Acad Sci USA 2006; 103: 9982-7.
9. PAPIN S, CUENIN S, AGOSTINI L et al.: The SPRY domain of Pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1beta processing. Cell Death Differ 2007; 14: 1457-66.
10. CATTAN D, DERVICHIAN M, THOMAS M, DODE C, TOUITOU I: MEFV mutations and phenotype-genotype correlations in North African Jews and Armenians with familial Mediterranean fever. Isr Med Assoc J 2001; 3: 803-4.
11. AKAR N, MISIROGLU M, YALCINKAYA F et al.: MEFV mutations in Turkish patients suffering from Familial Mediterranean Fever. Hum Mutat 2000; 15: 118-9.
12. BEN-CHETRIT E, URIELI-SHOVAL S, CALKO S, ABELIOVICH D, MATZNER Y: Molecular diagnosis of FMF: Lessons from a study of 446 unrelated individuals. Clin Exp Rheumatol 2002; 20: S25-9.
13. AKSENTJEVICH I, TOROSYAN Y, SAMUELS J et al.: Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population. Am J Hum Genet 1999; 64: 949-62.
14. CAZENEUVE C, HOVANNESYAN Z, GENEVIEVE D et al.: Familial Mediterranean fever among patients from Karabakh and the diagnostic value of MEFV gene analysis in all classically affected populations. Arthritis Rheum 2003; 48: 2324-31.
15. MAJEED HA, EL-KHATEEB M, EL-SHANTI H, RABAIHA ZA, TAYEH M, NAJIB D: The spectrum of familial Mediterranean fever gene mutations in Arabs: Report of a large series. Semin Arthritis Rheum 2005; 34: 813-8.
16. NOTARNICOLA C, DIDELOT MN, KONEPAUT I, SEGURET F, DEMAILLE J, TOUITOU I: Reduced MEFV messenger RNA expression in patients with familial Mediterranean fever. Arthritis Rheum 2002; 46: 2785-93.
17. USTEK D, EKMEKCI CG, SELCUKBIRICIK F et al.: Association between reduced levels of MEFV messenger RNA in peripheral blood leukocytes and acute inflammation. Arthritis Rheum 2007; 56: 345-50.
18. PAPIN S, CAZENEUVE C, DUQUESNOY P, JERU I, SAHALI D, AMSELEM S: The tumor necrosis factor alpha-dependent activation of the human Mediterranean fever (MEFV) promoter is mediated by a synergistic interaction between C/EBP beta and NF kappaB p65. J Biol Chem 2003; 278: 48839-47.
19. LIVNEH A, LANGEVITZ P, ZEMER D et al.: Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997; 40: 1879-85.
20. CENTOLA M, WOOD G, FRUCHT DM et al.: The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators. Blood 2000; 95: 3223-31.
21. ALDEA A, CALAFELL F, AROSTEGUI JI et al.: The west side story: MEFV haplotype in Spanish FMF patients and controls, and evidence of high LD and a recombination "hot-spot" at the MEFV locus. Hum Mutat 2004; 23: 399.
22. JERU I, HAYRAPETYAN H, DUQUESNOY P, SARKISIAN T, AMSELEM S: PYPAF1 nonsense mutation in a patient with an unusual autoinflammatory syndrome: Role of PYPAF1 in inflammation. Arthritis Rheum 2006; 54: 508-14.
23. AKARSU AN, SAATCI U, OZEN S, BAKKALOGLU A, BESBAS N, SARFARAZI M: Genetic linkage study of familial Mediterranean fever (FMF) to 16p13.3 and evidence for genetic heterogeneity in the Turkish population. J Med Genet 1997; 34: 573-8.
24. YILMAZ E, OZEN S, BALCI B et al.: Mutation frequency of Familial Mediterranean Fever and evidence for a high carrier rate in the Turkish population. Eur J Hum Genet 2001; 9: 553-5.
25. BATZER MA, DEININGER PL: Alu repeats and human genomic diversity. Nat Rev Genet 2002; 3:370-9.
26. DEININGER PL, BATZER MA: Alu repeats and human disease. Mol Genet Metab 1999; 67:183-93.
27. STUART JJ, EGRY LA, WONG GH, KASPAR RL: The 3′ UTR of human MnSOD mRNA hybridizes to a small cytoplasmic RNA and inhibits gene expression. Biochem Biophys Res Commun 2000; 274: 641-8.
28. YULUG IG, YULUG A, FISHER EM: The frequency and position of Alu repeats in cDNAs, as determined by database searching. Genomics 1995; 27: 544-8.
29. HASLER J, SAMUELSSON T, STRUB K: Useful 'junk': Alu RNAs in the human transcriptome. Cell Mol Life Sci 2007; 64: 1793-800.
30. WILSON GM, VASA MZ, DEELEY RG: Stabilization and cytoskeletal-association of LDL receptor mRNA are mediated by distinct domains in its 3′ untranslated region. J Lipid Res 1998; 39: 1025-32.